Analysis of Pneumocystis jirovecii DHPS alleles implicated in sulfamethoxazole resistance using an Escherichia coli model system

Microbial Drug Resistance

Volumn 11, Issue 1, 2005, Pages 1-8

  Iliades, Peter ^a   Meshnick, Steven R ^b   Macreadie, Ian G ^a  

^a CSIRO   (Australia)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DAPSONE; DIHYDROPTEROATE SYNTHASE; FAS ANTIGEN; FOLIC ACID; SULFACETAMIDE; SULFACHLORPYRIDAZINE; SULFADIAZINE; SULFADIMETHOXINE; SULFADOXINE; SULFAFURAZOLE; SULFAMERAZINE; SULFAMETHOXAZOLE; SULFAMETHOXYPYRIDAZINE; SULFANILAMIDE; SULFAQUINOXALINE; SULFATHIAZOLE;

ALLELE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM CULTURE; DRUG DIFFUSION; ESCHERICHIA COLI; FOL1 GENE; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; TREATMENT FAILURE;

AMINO ACID SUBSTITUTION; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENETIC VECTORS; MICROBIAL SENSITIVITY TESTS; MUTATION; PNEUMOCYSTIS; PNEUMONIA; SULFAMETHOXAZOLE; TRANSFORMATION, GENETIC;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; PNEUMOCYSTIS JIROVECII; SACCHAROMYCES CEREVISIAE;

EID: 14944372996     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2005.11.1     Document Type: Article

References (26)

1. Ansari, N.A., A.H. Kombe, T.A. Kenyon, L. Mazhani, N. Binkin, J.W. Tappero, T. Gebrekristos, S. Nyirenda, and S.B. Lucas. 2003. Pathology and causes of death in a series of human immunodeficiency virus-positive and -negative pediatric referral hospital admissions in Botswana. Pediatr. Infect. Dis. J. 22:43-47.
2. Armstrong, W., S. Meshnick, and P. Kazanjian. 2000. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients. Microbes Infect. 2:61-67.
3. Berglez, J., P. Iliades, W. Sirawaraporn, P. Coloe, and I. Macreadie. 2004. Analysis in Escherichia coli of Plasmodiumfalciparum dihydropteroate synthase (DHPS) alleles implicated in resistance to sulfadoxine. Int. J. Parasitol. 34:95-100.
4. Cohen, S.N., A.C. Chang, and L. Hsu. 1972. Non-chromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc. Natl. Acad. Sci. USA 69:2110-2114.
5. Demanche, C., J. Guillot, M. Berthelemy, T. Petitt, P. Roux, and A.E. Wakefield. 2002. Absence of mutations associated with sulfa resistance in Pneumocystis carinii dihydropteroate synthase gene from non-human primates. Med. Mycol. 40:315-318.
6. Fermer, C., and G. Swedberg. 1997. Adaptation to sulfonamide resistance in Neisseria meningitidis may have required compensatory changes to retain enzyme function: kinetic analysis of dihydropteroate synthases from N. meningitidis expressed in a knockout mutant of Escherichia coli. J. Bacteriol. 179:831-837.
7. Fisk, D.T., S. Meshnick, and P.H. Kazanjian. 2003. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin. Infect. Dis. 36:70-78.
8. Helweg-Larsen, J., T.L. Benfield, J. Eugen-Olsen, J.D. Lundgren, and B. Lundgren. 1999. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet 354:1347-1351.
9. Iliades, P., J. Berglez, S. Meshnick, and I. Macreadie. 2003. Promoter strength of folic acid synthesis genes affects sulfa drug resistance in Saccharomyces cerevisiae. Microb. Drug. Resist. 9:249-255.
10. Iliades, P., S.R. Meshnick, and I.G. Macreadie. 2004. Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model. Antimicrob. Agents Chemother. 48:2617-2623.
11. Kaplan, J.E., D.L. Hanson, T.R. Navin, and J.L. Jones. 1998. Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis. J. Infect. Dis. 178:1126-1132.
12. Kazanjian, P., A.B. Locke, P.A. Hossler, B.R. Lane, M.S. Bartlett, J.W. Smith, M. Cannon, and S.R. Meshnick. 1998. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS 12:873-878.
13. Kazanjian, P., W. Armstrong, P.A. Hossler, W. Burman, J. Richardson, C.H. Lee, L. Crane, J. Katz, and S.R. Meshnick. 2000. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J. Infect. Dis. 182:551-557.
14. Kovacs, J.A., V.J. Gill, S. Meshnick, and H. Masur. 2001. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. J. Am. Med. Assn. 286:2450-2460.
15. Lane, B.R., J.C. Ast, P.A. Hossler, O.P. Mindell, M.S. Bartlett, J.W. Smith, and S.R. Meshnick. 1997. Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J. Infect. Dis. 175: 482-485.
16. Ma, L., L. Borio, H. Masur, and J.A. Kovacs. 1999. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprimsulfamethoxazole or dapsone use. J. Infect. Dis. 180:1969-1978.
17. Ma, L., J.A. Kovacs, A. Cargnel, A. Valerio, G. Fantoni, and C. Atzori. 2002. Mutations in the dihydropteroate synthase gene of human-derived Pneuinocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J. Infect. Dis. 185:1530-1532.
18. Mei, Q., S. Gurunathan, H. Masur, and J.A. Kovacs. 1998. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene. Lancet 351:1631-1632.
19. Meneau, I., D. Sanglard, J. Bille, and P.M. Hauser. 2003. Site-directed mutagenesis of the Saccharomyces cerevisiae dihydropteroate synthase FOL1 gene to study Pneumocystis jirovecii mutations in the orthologue gene FAS. J. Eukaryot. Microbiol. 50(Suppl):652-653.
20. Meneau, I., D. Sanglard, J. Bille, and P.M. Hauser. 2004. Pneumocystis jirovecii dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 48:2610-2616.
21. Navin, T.R., C.B. Beard, L. Huang, C. del Rio, S. Lee, N.J. Pieniazek, J.L. Carter, T. Le, A. Hightower, and D. Rimland. 2001. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study. Lancet 358:545-549.
22. Sa-Filho, D.J., L.J. Costa, C.F. de Oliveira, A.P. Guimaraes, C.A. Accetturi, A. Tanuri, and R.S. Diaz. 2003. Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy. J. Clin. Virol. 28:186-202.
23. Takahashi, T., N. Hosoya, T. Endo, T. Nakamura, H. Sakashita, K. Kimura, K. Ohnishi, Y. Nakamura, and A. Iwamoto. 2000. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. Hominis isolates in Japan and resistance to sulfonamide therapy. J. Clin. Microbiol. 38:3161-3164.
24. Visconti, E., E. Ortona, P. Mencarini, P. Margutti, S. Marinaci, M. Zolfo, A. Siracusano, and E. Tamburrini. 2001. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. Int. J. Antimicrob. Agents 18:547-551.
25. Volpe, F., M. Dyer, J.G. Scaife, G. Darby, D.K. Stammers, and C.J. Delves. 1992. The multifunctional folic acid synthesis fas gene of Pneumocystis carinii appears to encode dihydropteroate synthase and hydroxymethyldihydropterin pyrophosphokinase. Gene 112:213-218.
26. Volpe, F., S.P. Ballantine, and C.J. Delves. 1993. The multifunctional folic acid synthesis fas gene of Pneumocystis carinii encodes dihydroneopterin aldolase, hydroxymethyldihydropterin pyrophosphokinase and dihydropteroate synthase. Eur. J. Biochem. 216:449-458.